The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Management of vasodilatory shock after cardiac surgery: Identification of predisposing factors and use of a novel pressor agent
Open accessAbstract
BACKGROUND: Cardiopulmonary bypass can be associated with vasodilatory hypotension requiring pressor support. We have previously found arginine vasopressin to be a remarkably effective pressor in a variety of vasodilatory shock states. We investigated the incidence and clinical predictors of vasodilatory shock in a general population of cardiac surgical patients and the effects of low-dose arginine vasopressin as treatment of this syndrome in patients with heart failure. METHODS: Patients undergoing cardiopulmonary bypass (n = 145) were studied prospectively. Preoperative ejection fraction, medications, and perioperative hemodynamics were recorded, and postbypass serum arginine vasopressin levels were measured. Vasodilatory shock was defined as a mean arterial pressure lower than 70 mm Hg, a cardiac index greater than 2.5 L/min/m2, and norepinephrine dependence. Predictors of vasodilatory shock were investigated by logistic regression analysis. The hemodynamic responses of patients who received arginine vasopressin infusions for vasodilatory shock after cardiopulmonary bypass for left ventricular assist device placement or heart transplantation were analyzed retrospectively. RESULTS: Eleven of 145 general cardiac surgery patients (8%) met criteria for postbypass vasodilatory shock. By multivariate analysis, an ejection fraction lower than 0.35 and angiotensin-converting enzyme inhibitor use were independent predictors of postbypass vasodilatory shock (relative risks of 9.1 and 11.9, respectively). Vasodilatory shock was associated with inappropriately low serum arginine vasopressin concentrations (12.0 +/- 6.6 pg/mL). Retrospective analysis found 40 patients with postbypass vasodilatory shock who received low-dose arginine vasopressin infusions, resulting in increased mean arterial pressure and decreased norepinephrine requirements. CONCLUSIONS: Low ejection fraction and angiotensin-converting enzyme inhibitor use are risk factors for postbypass vasodilatory shock, and this syndrome is associated with vasopressin deficiency. In patients exhibiting this syndrome after high-risk cardiac operations, replacement of arginine vasopressin increases blood pressure and reduces catecholamine pressor requirements.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Winquist, R. J., Faison, E. P., Waldman, S. A., Schwartz, K., Murad, F., & Rapoport, R. M. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.23.7661 · Cited by 497
Vasopressin pressor hypersensitivity in vasodilatory septic shock
Landry, D. W., Levin, H. R., Gallant, E. M., Seo, S., D'Alessandro, D., Oz, M. C., & Oliver, J. A. (1997) · Critical Care Medicine · doi:10.1097/00003246-199708000-00012 · Cited by 390
Self-citationJones, C. W., & Pickering, B. T. (1969) · The Journal of Physiology · doi:10.1113/jphysiol.1969.sp008874 · Cited by 234
Prospects for understanding and eliminating the deleterious effects of cardiopulmonary bypass
Kirklin, J. K. (1991) · The Annals of Thoracic Surgery · doi:10.1016/0003-4975(91)90302-7 · Cited by 221
Argenziano, M., Choudhri, A. F., Öz, M. C., Rose, E. A., Smith, C. R., & Landry, D. W. (1997) · PubMed · Cited by 211
Self-citationReversal of intractable septic shock with norepinephrine therapy
MEADOWS, D., EDWARDS, J. D., WILKINS, R. G., & NIGHTINGALE, P. (1988) · Critical Care Medicine · doi:10.1097/00003246-198807000-00003 · Cited by 210
Möhring, J., Glänzer, K., Maciel, J. A., Däsing, R., Kramer, H. J., Arbogast, R., & Koch-Weser, J. (1980) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-198007000-00004 · Cited by 158
Wakatsuki, T., Nakaya, Y., & Inoue, I. (1992) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1992.263.2.h491 · Cited by 150
Interleukin 1 inhibits contraction of vascular smooth muscle.
Beasley, D., Cohen, R. A., & Levinsky, N. G. (1989) · Journal of Clinical Investigation · doi:10.1172/jci113879 · Cited by 127
Chernow, B., & Roth, B. L. (1986) · PubMed · Cited by 122
Cited by
Vasopressin versus Norepinephrine Infusion in Patients with Septic Shock
Russell, J. A., Walley, K. R., Singer, J., Gordon, A. C., Hébert, P. C., Cooper, D. J., Holmes, C. L., Mehta, S., Granton, J. T., Storms, M. M., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa067373 · Cited by 1,924
Physiology of Vasopressin Relevant to Management of Septic Shock
Holmes, C. L., Patel, B. M., Russell, J. A., & Walley, K. R. (2001) · Chest · doi:10.1378/chest.120.3.989 · Cited by 620
Arginine Vasopressin in Advanced Vasodilatory Shock: A Prospective, Randomized, Controlled Study
Dünser, M. W., Mayr, A. J., Ulmer, H., Knotzer, H., Sumann, G., Pajk, W., Friesenecker, B., & Hasibeder, W. R. (2003) · Circulation · doi:10.1161/01.cir.0000066692.71008.bb · Cited by 525
Inotropes and Vasopressors: Review of Physiology and Clinical Use in Cardiovascular Disease
Overgaard, C. B., & Džavík, V. (2008) · Circulation · doi:10.1161/circulationaha.107.728840 · Cited by 516
2017 EACTS Guidelines on perioperative medication in adult cardiac surgery
Sousa-Uva*, M., Head, S. J., Milojevic, M., Collet, J.-P., Landoni, G., Castella, M., Dunning, J., Gudbjartsson, T., Linker, N. J., Sandoval, E., et al. (2018) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezx314 · Cited by 393
Metadata
- Authors
- Argenziano, M., Chen, J. M., Choudhri, A. F., Cullinane, S., Garfein, E., Weinberg, A. D., Smith, C. R., Rose, E. A., Landry, D. W., & Oz, M. C.
- Venue
- The Journal of Thoracic and Cardiovascular Surgery
- Publisher
- Elsevier BV
- Published
- 1998-12
- Volume
- 116
- Issue
- 6
- Pages
- 973-980
- ISSN
- 0022-5223 (ISSN-L)
- OpenAlex
- W2002359689
- Cited by
- 393
- References
- 17
- FWCI
- 11.47
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Management of vasodilatory shock after cardiac surgery: Identification of predisposing factors and use of a novel pressor agent. https://app.cochat.ai/papers/10.1016/s0022-5223(98)70049-2
- The paper
- Argenziano, M., Chen, J. M., Choudhri, A. F., Cullinane, S., Garfein, E., Weinberg, A. D., Smith, C. R., Rose, E. A., Landry, D. W., & Oz, M. C. (1998). Management of vasodilatory shock after cardiac surgery: Identification of predisposing factors and use of a novel pressor agent. The Journal of Thoracic and Cardiovascular Surgery. https://doi.org/10.1016/s0022-5223(98)70049-2
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.